DOCU:NASDAQDocuSign, Inc. Analysis
Data as of 2026-08-31 - not real-time
$64.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind DocuSign, Inc. is neutral at $64.00, with no clear ordering between short and long averages. The last 30 days have gained 21.4%. Relative strength is 63.1 — approaching overbought — and the MACD signal is bearish. Price has been bracketed by support at $54.26 and resistance at $65.64.
On valuation the read is overvalued — earnings multiple of 41.6 versus a 35.7 sector average, above the peer group. Consensus targets land 9.6% below where the shares trade now. Revenue is growing at 8.7% on a 9.6% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 63.2%, a beta of 0.66 and a maximum drawdown of 50.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
On valuation the read is overvalued — earnings multiple of 41.6 versus a 35.7 sector average, above the peer group. Consensus targets land 9.6% below where the shares trade now. Revenue is growing at 8.7% on a 9.6% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 63.2%, a beta of 0.66 and a maximum drawdown of 50.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
The latest trading day saw DocuSign DOCU settling at $58.In the latest trading session, DocuSign DOCU closed at $60.Grayson retains 126,429 shares worth about $7 million.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 53.68
- MACD momentum is negative
- 30-day price change of +21.4%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 41.6 versus sector average of 35.7
- Trading above the 200-day average of 53.68
- Analyst targets imply -9.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 41.6 versus sector average of 35.7
- Analyst targets imply -9.6% versus the current price
- Return on equity of 16.4%
Key Metrics & Analysis
Financial Health
Revenue Growth8.70%
Profit Margin9.59%
P/E Ratio41.6
ROE16.44%
ROA5.51%
Debt/Equity10.07
P/B Ratio6.8
Op. Cash Flow$1.2B
Free Cash Flow$1.3B
Industry P/E35.7
Technical Analysis
TrendNeutral
RSI63.1
Support$54.26
Resistance$65.64
MA 20$60.35
MA 50$53.39
MA 200$53.68
MACDBearish
VolumeStable
Fear & Greed Index94.34
Valuation
Fair Value$124.73
Target Price$57.88
Upside/Downside-9.57%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.66
Volatility63.22%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.